2017-03-14,TRACON Pharmaceuticals Announces $21 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
2017-03-06,TRACON Pharmaceuticals To Present At The 29th Annual Roth Conference
2017-02-28,TRACON Pharmaceuticals Reports Fourth Quarter And Year-End 2016 Financial Results And Provides Corporate Update
2017-02-21,TRACON To Report Fourth Quarter And Full Year 2016 Company Highlights And Financial Results On February 28, 2017
2017-02-16,TRACON Pharmaceuticals Announces First Patient Dosed In Phase 3 TAPPAS Trial Of TRC105 In Angiosarcoma
2017-02-09,TRACON Pharmaceuticals Announces Top-line Results From NCI-Sponsored Phase 2 Trial Of TRC105 In Recurrent Glioblastoma
2017-01-03,TRACON Pharmaceuticals Receives Special Protocol Assessment (SPA) Agreement From FDA For Phase 3 Clinical Trial Of TRC105 In Angiosarcoma
2016-11-29,TRACON Pharmaceuticals Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares
2016-11-23,TRACON Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2016-11-22,TRACON Pharmaceuticals To Host Key Opinion Leader Luncheon For Investors Focused On Angiosarcoma And Prostate Cancer On December 1 In New York City
2016-11-22,TRACON Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2016-11-13,TRACON Pharmaceuticals Presents Clinical And Preclinical Data From Models Of NASH And Liver Fibrosis At The 2016 AASLD Annual Meeting
2016-11-11,TRACON Pharmaceuticals Announces Presentation Of Updated Data From Phase 1b/2 Study Of TRC105 And Votrient® In Patients With Angiosarcoma
2016-11-08,TRACON Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Corporate Update
2016-11-07,TRACON Pharmaceuticals To Present At Upcoming Investment Conferences
2016-11-03,TRACON Pharmaceuticals Announces Clinical Data Presentation At Upcoming Connective Tissue Oncology Society (CTOS) 2016 Annual Meeting
2016-11-01,TRACON To Report Third Quarter 2016 Company Highlights And Financial Results On November 8, 2016
2016-10-20,TRACON Pharmaceuticals Reports Granting Of Inducement Awards
2016-10-09,TRACON Pharmaceuticals Presents Final Updated Phase 1b Results For TRC105 In Combination With Inlyta® In Renal Cell Carcinoma At The ESMO 2016 Congress
2016-10-03,TRACON Pharmaceuticals Announces Successful Meetings With FDA And EMA For TRC105 (carotuximab) In Angiosarcoma
2016-09-28,TRACON Pharmaceuticals Announces A Strategic Licensing Collaboration For Two Janssen Oncology Assets And A $5 Million Equity Investment From Johnson & Johnson Innovation - JJDC, Inc.
2016-08-31,TRACON Pharmaceuticals To Present At Upcoming Investment Conferences
2016-08-10,TRACON Pharmaceuticals Reports Second Quarter 2016 Financial Results And Provides Corporate Update
2016-08-03,TRACON To Report Second Quarter 2016 Company Highlights And Financial Results On August 10, 2016
2016-06-06,TRACON Pharmaceuticals Announces Positive Results From TRC105 And TRC102 Clinical Trials At American Society Of Clinical Oncology (ASCO) 2016 Annual Meeting
2016-05-31,TRACON Pharmaceuticals To Present At Upcoming Investment Conferences
2016-05-20,TRACON Pharmaceuticals Reports Granting Of Inducement Award
2016-05-18,TRACON Pharmaceuticals Initiates Dosing In Phase 1b/2 Study Of TRC105 In Patients With Hepatocellular Carcinoma
2016-05-16,TRACON Pharmaceuticals To Present At The UBS Global Healthcare Conference
2016-05-11,TRACON Pharmaceuticals Reports First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-09,TRACON Pharmaceuticals Announces Initiation Of Dosing In A Phase 1/2 Neoadjuvant Study Of TRC105 In Patients With Breast Cancer
2016-05-04,TRACON To Report First Quarter 2016 Company Highlights And Financial Results On May 11, 2016
2016-05-04,TRACON Announces EMA Orphan Drug Designation For TRC105 In Soft Tissue Sarcoma
2016-04-21,TRACON Announces Clinical Data Presentations At Upcoming ASCO Annual Meeting
2016-04-11,TRACON Pharmaceuticals Announces TRC105 Clinical Data Presentation At Upcoming AACR Annual Meeting
2016-04-05,TRACON Pharmaceuticals To Present At The 15th Annual Needham Healthcare Conference
2016-03-28,Ratings Changes Today
2016-03-21,TRACON Pharmaceuticals Reports Updated Positive Data On Ongoing Complete Response In Choriocarcinoma Patient Treated With TRC105
2016-03-14,TRACON Pharmaceuticals Initiates Phase 1b Study Of TRC105 In Patients With Lung Cancer
2016-03-07,TRACON Pharmaceuticals Reports Granting Of Inducement Awards
2016-03-07,TRACON Pharmaceuticals To Present At The 28th Annual Roth Conference
2016-02-18,TRACON Pharmaceuticals Reports Fourth Quarter And Year-End 2015 Financial Results And Provides Corporate Update
2016-02-11,TRACON To Report Fourth Quarter And Full Year 2015 Company Highlights And Financial Results On February 18, 2016
2016-01-27,TRACON Pharmaceuticals Announces Initiation Of TRC102 Phase 2 Clinical Trial In Glioblastoma
2016-01-25,TRACON Announces FDA Orphan Drug Designation For TRC105 In Soft Tissue Sarcoma
2015-12-02,TRACON Pharmaceuticals To Present At The Oppenheimer 26th Annual Healthcare Conference
2015-11-11,TRACON Pharmaceuticals To Present At The Stifel 2015 Healthcare Conference
2015-11-06,TRACON Pharmaceuticals Presents Positive Updated Phase 1b Results For TRC105 In Combination With Inlyta® At The 2015 Kidney Cancer Association Meeting
2015-11-05,TRACON Pharmaceuticals Presents Positive Interim Results From TRC105 Trial In Sarcoma At The Connective Tissue Oncology Society (CTOS) 2015 Annual Meeting
2015-11-04,TRACON Pharmaceuticals To Host Investor Meeting Featuring Key Opinion Leaders On November 13 In New York City
2015-11-03,TRACON Pharmaceuticals Reports Third Quarter 2015 Results And Provides Corporate Update
2015-10-29,TRACON Pharmaceuticals Announces Clinical Data Presentations At Upcoming Medical Meetings
2015-10-27,TRACON To Report Third Quarter 2015 Company Highlights And Financial Results On November 3, 2015
2015-10-12,TRACON Pharmaceuticals Announces Initiation Of TRC102 Combination Phase 1b/2 Trial
2015-10-06,TRACON Pharmaceuticals Announces Appointment Of Ronald Shazer, M.D., M.B.A., As Chief Medical Officer
2015-09-18,Market News: Freeport-McMoRan, La Quinta, TRACON Pharmaceuticals
2015-09-18,TRACON Pharmaceuticals Reports Ongoing Complete Response In Choriocarcinoma Patient Treated With Company's TRC105 In Compassionate Use Phase 2 Clinical Trial Conducted At Dana-Farber Cancer Institute
2015-09-02,TRACON Pharmaceuticals To Present At Upcoming Investment Conferences
2015-08-05,TRACON Pharmaceuticals Reports Second Quarter 2015 Financial Results And Provides Corporate Update
2015-07-29,TRACON To Report Second Quarter 2015 Company Highlights And Financial Results On August 5, 2015
2015-07-01,TRACON Pharmaceuticals Announces IND Filing Of DE-122 (TRC105) For The Treatment Of Wet Age-Related Macular Degeneration By Santen Pharmaceutical
2015-06-18,UPDATE -- TRACON Pharmaceuticals To Present At The JMP Securities Life Science Conference
2015-06-17,TRACON Pharmaceuticals To Present At The JMP Securities Life Science Conference
2015-06-01,TRACON Pharmaceuticals Announces Positive Results Of TRC105 Clinical Trials In Sarcoma And Liver Cancer At The American Society Of Clinical Oncology (ASCO) 2015 Annual Meeting
2015-05-15,6 Stocks Spiking on Big Volume
2015-05-14,TRACON's TRC105 Receives FDA Fast Track Designation
2015-05-13,TRACON Announces Clinical Data Presentations At Upcoming ASCO Annual Meeting
2015-05-13,TRACON Pharmaceuticals Reports First Quarter 2015 Financial Results And Provides Corporate Update
2015-05-11,TRACON Pharmaceuticals To Present At The UBS Global Healthcare Conference
2015-05-06,TRACON To Report First Quarter 2015 Company Highlights And Financial Results On May 13, 2015
2015-04-13,TRACON Pharmaceuticals Announces Data Presentations At Upcoming AACR Annual Meeting
2015-04-08,TRACON Pharmaceuticals Expands License Agreement And Signs Research Agreement With Case Western Reserve University
2015-04-07,TRACON Pharmaceuticals To Present At The 14th Annual Needham Healthcare Conference
2015-03-10,TRACON Pharmaceuticals Reports 2014 Year-End Financial Results And Recent Corporate Highlights
2015-03-02,Market News: TRACON Pharmaceuticals, NXP Semiconductor, Omeros
2015-02-28,TRACON Pharmaceuticals Announces Positive Phase 1b Results For TRC105 In Combination With Inlyta(R) (axitinib) At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium
2015-02-27,TRACON Pharmaceuticals Appoints Stephen Worland To Its Board Of Directors
2015-02-24,Market News: Tesla Motors, TRACON Pharmaceuticals, Qorvo
2015-02-19,TRACON Pharmaceuticals Announces Upcoming Presentation Of Results From A Clinical Trial Of TRC105 In Patients With Renal Cell Carcinoma At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium
2015-01-30,IPO Roundup: Shake Shack Shares More Than Double Out of Gate
,
,
,
